Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8582 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.844 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8071 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7862 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7764 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7703 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7568 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7515 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4966 |
Approved |
0.75 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7485 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7396 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7378 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7317 |
Intermediate Similarity |
NPD37 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7278 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7257 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7257 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7152 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7119 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7102 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7089 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7052 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD2157 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD7119 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6977 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6971 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6966 |
Remote Similarity |
NPD6671 |
Approved |
0.6962 |
Remote Similarity |
NPD5588 |
Approved |
0.6962 |
Remote Similarity |
NPD3748 |
Approved |
0.6959 |
Remote Similarity |
NPD5494 |
Approved |
0.6957 |
Remote Similarity |
NPD7003 |
Approved |
0.6949 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6939 |
Remote Similarity |
NPD7741 |
Discontinued |
0.6928 |
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD8099 |
Discontinued |
0.6914 |
Remote Similarity |
NPD8251 |
Approved |
0.6914 |
Remote Similarity |
NPD8252 |
Approved |
0.6905 |
Remote Similarity |
NPD1934 |
Approved |
0.6894 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD2533 |
Approved |
0.689 |
Remote Similarity |
NPD7020 |
Approved |
0.689 |
Remote Similarity |
NPD2534 |
Approved |
0.689 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD2532 |
Approved |
0.689 |
Remote Similarity |
NPD7019 |
Approved |
0.6887 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6887 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6879 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6875 |
Remote Similarity |
NPD7843 |
Approved |
0.6875 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6868 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD4624 |
Approved |
0.6855 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6849 |
Remote Similarity |
NPD7157 |
Approved |
0.6848 |
Remote Similarity |
NPD6273 |
Approved |
0.6846 |
Remote Similarity |
NPD4626 |
Approved |
0.6842 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6832 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD3091 |
Approved |
0.6821 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6818 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6815 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD7906 |
Approved |
0.6813 |
Remote Similarity |
NPD2796 |
Approved |
0.6803 |
Remote Similarity |
NPD7340 |
Approved |
0.6797 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6796 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6792 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD4536 |
Approved |
0.6792 |
Remote Similarity |
NPD4538 |
Approved |
0.6784 |
Remote Similarity |
NPD7773 |
Phase 2 |
0.6784 |
Remote Similarity |
NPD3882 |
Suspended |
0.6783 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.678 |
Remote Similarity |
NPD7054 |
Approved |
0.6779 |
Remote Similarity |
NPD5691 |
Approved |
0.6776 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6776 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6768 |
Remote Similarity |
NPD6667 |
Approved |
0.6768 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6768 |
Remote Similarity |
NPD6666 |
Approved |
0.6766 |
Remote Similarity |
NPD1653 |
Approved |
0.6761 |
Remote Similarity |
NPD2342 |
Discontinued |
0.6755 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6755 |
Remote Similarity |
NPD1091 |
Approved |
0.6755 |
Remote Similarity |
NPD3092 |
Approved |
0.6752 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.675 |
Remote Similarity |
NPD4108 |
Discontinued |
0.675 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.675 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6744 |
Remote Similarity |
NPD7833 |
Phase 2 |
0.6744 |
Remote Similarity |
NPD7831 |
Phase 2 |
0.6744 |
Remote Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.6743 |
Remote Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.6742 |
Remote Similarity |
NPD7472 |
Approved |
0.674 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6733 |
Remote Similarity |
NPD5846 |
Approved |
0.6733 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6731 |
Remote Similarity |
NPD7095 |
Approved |
0.6727 |
Remote Similarity |
NPD1511 |
Approved |
0.6722 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6722 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6712 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6711 |
Remote Similarity |
NPD1840 |
Phase 2 |
0.6711 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.671 |
Remote Similarity |
NPD1712 |
Approved |
0.671 |
Remote Similarity |
NPD5736 |
Approved |
0.6708 |
Remote Similarity |
NPD5406 |
Approved |
0.6708 |
Remote Similarity |
NPD5405 |
Approved |
0.6708 |
Remote Similarity |
NPD5408 |
Approved |
0.6708 |
Remote Similarity |
NPD5404 |
Approved |
0.6707 |
Remote Similarity |
NPD7427 |
Discontinued |
0.6706 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6703 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6691 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.669 |
Remote Similarity |
NPD968 |
Approved |
0.6688 |
Remote Similarity |
NPD2797 |
Approved |
0.6688 |
Remote Similarity |
NPD3764 |
Approved |
0.6686 |
Remote Similarity |
NPD3051 |
Approved |
0.6685 |
Remote Similarity |
NPD4578 |
Approved |
0.6685
|
Remote Similarity |
NPD4577 |
Approved |